Bacteria Develop Resistance to Cell-Penetrating Peptide Antibiotics Through Stress Response
E. coli resists arginine-rich cell-penetrating peptide delivery of antimicrobials by activating the Cpx stress response, which decreases membrane potential and blocks energy-dependent peptide uptake.
Quick Facts
What This Study Found
E. coli resistance to CPP-delivered antimicrobials requires constitutive Cpx stress response activation (cpx*), which decreases cytoplasmic membrane potential and blocks energy-dependent uptake of arginine-rich CPP conjugates.
Key Numbers
Multiple genetic modifications required; cpx* reduces membrane potential; cross-resistance to aminoglycosides; resistance specific to CPP not PNA
How They Did This
Bacterial genetics study. Resistance mutants selected against PNA-CPP conjugates in E. coli. Genetic characterization of resistance mechanisms. Cpx pathway analysis. Membrane potential measurements. Cross-resistance testing with aminoglycosides and other CPP conjugates.
Why This Research Matters
CPP-delivered antimicrobials are a promising strategy against antibiotic-resistant bacteria. Understanding how bacteria resist this approach is essential for designing CPP-based antibiotics that avoid resistance development.
The Bigger Picture
As antibiotic resistance grows, CPP-delivered antimicrobials represent a novel strategy. This study reveals that bacteria can adapt by disrupting the energy-dependent uptake pathway, but the requirement for multiple mutations suggests resistance development may be slower than for conventional antibiotics.
What This Study Doesn't Tell Us
E. coli laboratory study — resistance mechanisms may differ in other bacteria. In vitro conditions may not reflect in vivo resistance development. Clinical significance of Cpx-mediated resistance is unknown.
Questions This Raises
- ?Can CPP-antimicrobial conjugates be designed to bypass the Cpx resistance mechanism?
- ?How quickly does Cpx-mediated resistance develop in clinical infection settings?
- ?Would combining CPP-antimicrobials with drugs that maintain membrane potential prevent resistance?
Trust & Context
- Key Stat:
- Multiple mutations required Resistance to CPP-delivered antimicrobials required multiple genetic modifications, suggesting a higher barrier to resistance than conventional antibiotics
- Evidence Grade:
- Moderate evidence: well-designed mechanistic study with genetic validation, but limited to E. coli laboratory strains.
- Study Age:
- Published 2021. CPP-antimicrobial research continues with increasing focus on overcoming resistance mechanisms.
- Original Title:
- Activating the Cpx response induces tolerance to antisense PNA delivered by an arginine-rich peptide in Escherichia coli.
- Published In:
- Molecular therapy. Nucleic acids, 25, 444-454 (2021)
- Authors:
- Frimodt-Møller, Jakob, Koulouktsis, Andreas, Charbon, Godefroid, Otterlei, Marit, Nielsen, Peter E, Løbner-Olesen, Anders
- Database ID:
- RPEP-05390
Evidence Hierarchy
Frequently Asked Questions
What are cell-penetrating peptides used for in antibiotic development?
CPPs are short peptide chains that can carry antimicrobial cargo across bacterial membranes that would normally block drug entry. By conjugating antibiotics to CPPs, researchers can deliver drugs directly into bacteria — a strategy to fight antibiotic-resistant infections.
Can bacteria become resistant to CPP-based antibiotics?
This study shows they can, but with difficulty. Resistance required multiple genetic changes and involved reducing the membrane energy that CPPs need to enter cells. The high barrier to resistance is actually encouraging for future CPP-antibiotic development.
Read More on RethinkPeptides
Cite This Study
https://rethinkpeptides.com/research/RPEP-05390APA
Frimodt-Møller, Jakob; Koulouktsis, Andreas; Charbon, Godefroid; Otterlei, Marit; Nielsen, Peter E; Løbner-Olesen, Anders. (2021). Activating the Cpx response induces tolerance to antisense PNA delivered by an arginine-rich peptide in Escherichia coli.. Molecular therapy. Nucleic acids, 25, 444-454. https://doi.org/10.1016/j.omtn.2021.06.009
MLA
Frimodt-Møller, Jakob, et al. "Activating the Cpx response induces tolerance to antisense PNA delivered by an arginine-rich peptide in Escherichia coli.." Molecular therapy. Nucleic acids, 2021. https://doi.org/10.1016/j.omtn.2021.06.009
RethinkPeptides
RethinkPeptides Research Database. "Activating the Cpx response induces tolerance to antisense P..." RPEP-05390. Retrieved from https://rethinkpeptides.com/research/frimodt-moller-2021-activating-the-cpx-response
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.